Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/ PD-L1/PD-L2 alterations

Marthe Minderman, Avital Amir, Willem Kraan, Esther J. M. Schilder-Tol, Monique E. C. M. Oud, Cornelis G. Scheepstra, Arnold L. Noorduyn, Philip M. Kluin, Marie José Kersten, Marcel Spaargaren, Steven T. Pals

Blood (2021) 138 (13): 1194–1197.

https://doi.org/10.1182/blood.2021011366

Published: 2021

Includes: Supplemental data

Journal Articles

The missing link in early follicular lymphoma development

Philip M. Kluin

Blood (2014) 123 (22): 3371–3372.

https://doi.org/10.1182/blood-2014-04-566828

Published: 2014

Journal Articles

Visibility Of Bone Lesions In Relapsed Multiple Myeloma Can Be Improved By FDG-PET Scanning

Esther G.M. De Waal, MD, Riemer H.J.A. Slart, MD, PhD, Marnix J. Leene, Philip M. Kluin, MD, PhD, Edo Vellenga, MD, PhD

Blood (2013) 122 (21): 5323.

https://doi.org/10.1182/blood.V122.21.5323.5323

Published: 2013

Journal Articles

Double-hit B-cell lymphomas

Sietse M. Aukema, Reiner Siebert, Ed Schuuring, Gustaaf W. van Imhoff, Hanneke C. Kluin-Nelemans, Evert-Jan Boerma, Philip M. Kluin

Blood (2011) 117 (8): 2319–2331.

https://doi.org/10.1182/blood-2010-09-297879

Published: 2011

Includes: Supplemental data

Journal Articles

The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment

Febe van Maldegem, Remco van Dijk, Thera A. M. Wormhoudt, Philip M. Kluin, Rein Willemze, Lorenzo Cerroni, Carel J. M. van Noesel, Richard J. Bende

Blood (2008) 112 (8): 3355–3361.

https://doi.org/10.1182/blood-2008-01-132415

Published: 2008

Includes: Supplemental data

Journal Articles

Differences in the C13orf25 miRNA Cluster in Non-Hodgkin Lymphoma and Normal B-Cell Subtypes.

Jan-Lukas Robertus, MD, Miao Wang, MD, Geert Harms, MSc, Tjasso Blokzijl, MSc, Rikst Nynke Schakel, MSc, Daphne de Jong, MD PhD, Rogier M. Reijmers, MSc, Steven T. Pals, MD PhD, Stefano Rosati, MD, Ed Schuuring, PhD, Philip M. Kluin, MD PhD, Anke van den Berg, PhD

Blood (2007) 110 (11): 3586.

https://doi.org/10.1182/blood.V110.11.3586.3586

Published: 2007

Journal Articles

MicroRNAs Specific for Immune-Privileged Diffuse Large B-Cell Lymphoma.

JanLukas Robertus, MD, Geert Harms, MSc, Tjasso Blokzijl, MSc, Daphne de Jong, MD PhD, Marije Booman, Ir, Stefano Rosati, MD, Ed Schuuring, PhD, Philip M. Kluin, MD PhD, Anke van den Berg, PhD

Blood (2007) 110 (11): 1566.

https://doi.org/10.1182/blood.V110.11.1566.1566

Published: 2007

Journal Articles

Gene Expression Profiling Can Predict Responsiveness to Chemotherapy in Patients with Transformation of Follicular Lymphoma.

Marie Jose Kersten, MD, PhD, Annuska M. Glas, PhD, Leonie J. Delahaye, Robby E. Kibbelaar, MD, PhD, Han H. van Krieken, MD, PhD, Philip M. Kluin, MD, PhD, Laura van ‘t Veer, PhD, Daphne de Jong, MD, PhD

Blood (2006) 108 (11): 823.

https://doi.org/10.1182/blood.V108.11.823.823

Published: 2006

Journal Articles

Hypermutation in Mantle Cell Lymphoma Does Not Indicate a Clinical or Biological Sub Entity.

Margit Schraders, Sabine Oeshker, Philip M. Kluin, Konnie Hebeda, Ed Schuuring, Martin-Leo Hansmann, Patricia J.T.A. Groenen, Joannes H.J.M. Van Krieken

Blood (2006) 108 (11): 2047.

https://doi.org/10.1182/blood.V108.11.2047.2047

Published: 2006

Journal Articles

Quantitative RT-PCR analysis of activation-induced cytidine deaminase expression in tissue samples from mantle cell lymphoma and B-cell chronic lymphocytic leukemia patients

Jeroen E. J. Guikema, Stefano Rosati, Karine Akkermans, Richard J. Bende, Carel J. M. van Noesel, Johan H. van Krieken, Martin L. Hansmann, Ed Schuuring, Philip M. Kluin

Blood (2005) 105 (7): 2997–2999.

https://doi.org/10.1182/blood-2004-09-3473

Published: 2005

Journal Articles

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

Annuska M. Glas, Marie José Kersten, Leonie J. M. J. Delahaye, Anke T. Witteveen, Robby E. Kibbelaar, Arno Velds, Lodewyk F. A. Wessels, Peter Joosten, Ron M. Kerkhoven, René Bernards, Johan H. J. M. van Krieken, Philip M. Kluin, Laura J. van't Veer, Daphne de Jong

Blood (2005) 105 (1): 301–307.

https://doi.org/10.1182/blood-2004-06-2298

Published: 2005

Includes: Supplemental data

Journal Articles

Altered Replication Timing of IGH Alleles in Burkitt’s Lymphoma Depends on IGH Breakpoint Position.

Jeroen E.J. Guikema, PhD, Conny de Boer, Jules Gadiot, Ed Schuuring, PhD, Philip M. Kluin, MD, PhD

Blood (2004) 104 (11): 4276.

https://doi.org/10.1182/blood.V104.11.4276.4276

Published: 2004

Journal Articles

Gene Expression Profiles Are Best Suited To Assess Present Though Not Future Clinical Aggressiveness in Follicular Lymphoma.

Annuska M. Glas, PhD, Marie Jose Kersten, MD, PhD, Leonie Delahaye, Robby E. Kibbelaar, MD, PhD, Joannes H.J.M. Van Krieken, MD, PhD, Philip M. Kluin, MD, PhD, Laura J. van ‘t Veer, PhD, Daphne de Jong, MD, PhD

Blood (2004) 104 (11): 698.

https://doi.org/10.1182/blood.V104.11.698.698

Published: 2004

Journal Articles

The Grey Zone between Burkitt and Diffuse Large B Cell Lymphomas: Impact of Chromosomal Breakponts at Myc and Other Loci.

Eugenia Haralambieva, Evert-jan Boerma, Gustaaf van Imhoff, MD, Stefano Rosati, MD, Ed Schuuring, PhD, Hans-Konrad Mueller-Hermelink, MD PhD, Philip M. Kluin, MD PhD, German Ott, MD PhD

Blood (2004) 104 (11): 2275.

https://doi.org/10.1182/blood.V104.11.2275.2275

Published: 2004

Journal Articles

Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels

Katja Specht, Eugenia Haralambieva, Karin Bink, Marcus Kremer, Sonja Mandl-Weber, Ina Koch, Raju Tomer, Heinz Hofler, Ed Schuuring, Philip M. Kluin, Falko Fend, Leticia Quintanilla-Martinez

Blood (2004) 104 (4): 1120–1126.

https://doi.org/10.1182/blood-2003-11-3837

Published: 2004

Journal Articles

Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients

Marcel W. Bekkenk, Maarten H. Vermeer, Patty M. Jansen, Ariënne M. W. van Marion, Marijke R. Canninga-van Dijk, Philip M. Kluin, Marie-Louise Geerts, Chris J. L. M. Meijer, Rein Willemze

Blood (2003) 102 (6): 2213–2219.

https://doi.org/10.1182/blood-2002-07-1960

Published: 2003

Journal Articles

Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive

Anneke G. Bosga-Bouwer, Gustaaf W. van Imhoff, Ronald Boonstra, Anneke van der Veen, Eugenia Haralambieva, Anke van den Berg, Bauke de Jong, Vanessa Krause, Martin C. Palmer, Robert Coupland, Philip M. Kluin, Eva van den Berg, Sibrand Poppema

Blood (2003) 101 (3): 1149–1154.

https://doi.org/10.1182/blood.V101.3.1149

Published: 2003

Journal Articles

Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells

James A. L. Fenton, Jan-Willem Vaandrager, Wilhelmina M. Aarts, Richard J. Bende, Karel Heering, Martin van Dijk, Gareth Morgan, Carel J. M. van Noesel, Ed Schuuring, Philip M. Kluin

Blood (2002) 99 (2): 716–718.

https://doi.org/10.1182/blood.V99.2.716

Published: 2002

Journal Articles

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites

Sietske A. Riemersma, Ekaterina S. Jordanova, Roelandt F. J. Schop, Katja Philippo, Leendert H. J. Looijenga, Ed Schuuring, Philip M. Kluin

Blood (2000) 96 (10): 3569–3577.

https://doi.org/10.1182/blood.V96.10.3569

Published: 2000

Journal Articles

V(D)J recombinase-mediated transposition of the BCL2 gene to the IGH locus in follicular lymphoma

Jan-Willem Vaandrager, Ed Schuuring, Katja Philippo, Philip M. Kluin

Blood (2000) 96 (5): 1947–1952.

https://doi.org/10.1182/blood.V96.5.1947

Published: 2000

NARROW

Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/ PD-L1/PD-L2 alterations

The missing link in early follicular lymphoma development

Visibility Of Bone Lesions In Relapsed Multiple Myeloma Can Be Improved By FDG-PET Scanning

Double-hit B-cell lymphomas

The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment

Differences in the C13orf25 miRNA Cluster in Non-Hodgkin Lymphoma and Normal B-Cell Subtypes.

MicroRNAs Specific for Immune-Privileged Diffuse Large B-Cell Lymphoma.

Gene Expression Profiling Can Predict Responsiveness to Chemotherapy in Patients with Transformation of Follicular Lymphoma.

Hypermutation in Mantle Cell Lymphoma Does Not Indicate a Clinical or Biological Sub Entity.

Quantitative RT-PCR analysis of activation-induced cytidine deaminase expression in tissue samples from mantle cell lymphoma and B-cell chronic lymphocytic leukemia patients

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

Altered Replication Timing of IGH Alleles in Burkitt’s Lymphoma Depends on IGH Breakpoint Position.

Gene Expression Profiles Are Best Suited To Assess Present Though Not Future Clinical Aggressiveness in Follicular Lymphoma.

The Grey Zone between Burkitt and Diffuse Large B Cell Lymphomas: Impact of Chromosomal Breakponts at Myc and Other Loci.

Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels

Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients

Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive

Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites

V(D)J recombinase-mediated transposition of the BCL2 gene to the IGH locus in follicular lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only